Sacrospinous Ligament Fixation vs Ischial Spine Fascia Fixation

January 14, 2026 updated by: Peking Union Medical College Hospital

A Prospective, Randomized Comparison of Efficacy and Effect on Quality of Life Between Sacrospinous Ligament Fixation and Ischial Spine Fascia Fixation

A Prospective, Randomized Comparison of Efficacy and Effect on Quality of Life Between Sacrospinous Ligament Fixation and Ischial Spine Fascia Fixation.

Study Overview

Detailed Description

Investigational intervention:SSLF or ISFF operations

Study title:A Prospective, Randomized Comparison of Efficacy and Effect on Quality of Life Between Sacrospinous Ligament Fixation and Ischial Spine Fascia Fixation.

Principal Investigator:Chang Ren, M.D., Department of Obstetrics & Gynecology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College.

Study subjects:Adult patients with symptomatic stage II~IV pelvic organ prolapse will be eligible if all the inclusion criteria are met and without any reason for exclusion.

Study objectives:The primary objective of this study is to assess the short and mid-term efficacy of Sacrospinous Ligament Fixation and Ischial Spine Fascia Fixation in treating stage II~ IV pelvic organ prolapse and their recurrence rate as well as their impacts on quality of life.

Study design:Prospective, Single-Blind, Randomized, Clinical Trial

Intervention:

  • ISFF group:Patients receive ISFF according to randomization.
  • SSLF group:Patients receive SSLF according to randomization

Sample size:76 patients (38 in ISFF group, 38 in SSLF group)

Primary endpoint:

•objective success rates at 3 months after operations.

Secondary endpoints:

  • peri-operative parameters .
  • subjective satisfactory rates at 1 year after operations
  • quality of life questionnaires at 1 year after operations

Safety endpoints: complications

Study Type

Interventional

Enrollment (Actual)

76

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Beijing Municipality
      • Beijing, Beijing Municipality, China, 100730
        • Department of Ob & Gyn, Peking Union Medical College Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

25 years to 65 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • age≤65 years, for those scheduled to receive hysterectomy age≥40 years
  • patients with symptomatic stage II~IV uterine or vaginal vault prolapse
  • receiving SSLF or ISFF in the gynecological department at Peking Union Medical College Hospital

Exclusion Criteria:

  • plans to live abroad within follow-up span
  • contradiction to these two operations: acute genital infection, narrow vagina (less than two finger-breadth), too-ill to receive operations
  • patients with hip joint problem who could not pose a lithotomy position

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: sacrospinous ligament fixation group
The patients will receive sacrospinous ligament fixation operation.
The participants will receive sacrospinous ligament fixation.
Experimental: ischial spine fascia fixation group
The patients will receive ischial spine fascia fixation operation.
The participants will receive ischial spine fascia fixation.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
objective success
Time Frame: 3 months after operation
no prolapse, stage I or only asymptomatic stage II prolapse
3 months after operation

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Pelvic Floor Distress Inventory-20 (PFDI-20)
Time Frame: Change from Baseline in PFDI-20 at 3 months and 1 year
to evaluate the quality of life in 3 domains
Change from Baseline in PFDI-20 at 3 months and 1 year
Pelvic Floor Impact Questionnaire-7 (PFIQ-7)
Time Frame: Change from Baseline in PFIQ-7 at 3 months and 1 year
to evaluate the quality of life in 3 domains
Change from Baseline in PFIQ-7 at 3 months and 1 year
Pelvic Organ Prolapse/Urinary Incontinence Sexual Questionnaire-12 (PISQ-12)
Time Frame: Change from Baseline in PISQ-12 at 3 months and 1 year
to evaluate the sexual function
Change from Baseline in PISQ-12 at 3 months and 1 year
complications
Time Frame: through study completion, an average of 1 year
peri-operative:massive bleeding, organ injury; post-operative: pelvic hematoma, pain, de novo UI, de novo dyspareunia
through study completion, an average of 1 year
recurrence rate
Time Frame: 3 months after operation
more than asymptomatic stage II prolapse after 3 months
3 months after operation
subjective satisfaction ( according to a scale of 5 degrees: significantly worse, worse, no change, improved, greatly improved)
Time Frame: 1 year after operation
Patient's response as improved or greatly improved
1 year after operation

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Chang Ren, M.D., Peking Union Medical College Hospital

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 15, 2017

Primary Completion (Actual)

February 1, 2023

Study Completion (Actual)

February 1, 2023

Study Registration Dates

First Submitted

December 15, 2016

First Submitted That Met QC Criteria

December 28, 2016

First Posted (Estimated)

December 29, 2016

Study Record Updates

Last Update Posted (Estimated)

January 16, 2026

Last Update Submitted That Met QC Criteria

January 14, 2026

Last Verified

February 1, 2023

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Urogenital Prolapse

Clinical Trials on sacrospinous ligament fixation

Subscribe